VSTM Verastem Forecast, Technical & Fundamental Analysis
a company that discovers and develops drugs
VSTM in -2.41% downward trend, declining for three consecutive days on September 08, 2023
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where VSTM declined for three days, in of 322 cases, the price declined further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 19, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on VSTM as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
VSTM moved below its 50-day moving average on September 19, 2023 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for VSTM crossed bearishly below the 50-day moving average on September 15, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for VSTM entered a downward trend on September 25, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VSTM advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .
VSTM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VSTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.361) is normal, around the industry mean (22.637). P/E Ratio (0.000) is within average values for comparable stocks, (131.508). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.084). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (31.271) is also within normal values, averaging (304.948).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VSTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a company that discovers and develops drugs
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PMAPX | 20.53 | 0.12 | +0.59% |
| Principal MidCap S&P 400 Index R-6 | |||
| JAGCX | 36.69 | 0.16 | +0.44% |
| Janus Henderson Glb Tech and Innovt C | |||
| WGUSX | 12.14 | 0.04 | +0.33% |
| Wasatch US Select Inst | |||
| HFEAX | 39.96 | -0.19 | -0.47% |
| Janus Henderson European Focus A | |||
| EPVIX | 9.55 | -0.10 | -1.04% |
| EuroPac International Value I | |||
VSTM and
Correlation & Price change
A.I.dvisor indicates that over the last year, VSTM has been closely correlated with PBLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if VSTM jumps, then PBLA could also see price increases.
| Ticker / NAME | Correlation To VSTM | 1D Price Change % | ||
|---|---|---|---|---|
| VSTM | 100% | -3.40% | ||
| PBLA - VSTM | 77% Closely correlated | +0.81% | ||
| LABP - VSTM | 60% Loosely correlated | -0.26% | ||
| ITOS - VSTM | 44% Loosely correlated | -2.71% | ||
| CYTK - VSTM | 41% Loosely correlated | -3.13% | ||
| TGTX - VSTM | 38% Loosely correlated | -1.75% | ||
More | ||||
Groups containing VSTM
Correlation & Price change
| Ticker / NAME | Correlation To VSTM | 1D Price Change % |
|---|---|---|
| VSTM | 100% | -3.40% |
| drugs (undefined stocks) | 28% Poorly correlated | -1.35% |
| biotechnology (undefined stocks) | 27% Poorly correlated | -1.59% |
| VSTM (undefined stocks) | 26% Poorly correlated | -1.30% |